| Literature DB >> 35150292 |
Pawel A Sokal1,2, Richard Norris1,3, Thomas W Maddox1,4, Rachel A Oldershaw5.
Abstract
PURPOSE: The diagnostic accuracy of clinical tests for anterior cruciate ligament injury has been reported in previous systematic reviews. Numerous studies in these reviews include subjects with additional knee ligament injury, which could affect the sensitivity of the tests. Meta-analyses have also been performed using methods that do not account for the non-independence of sensitivity and specificity, potentially overestimating diagnostic accuracy. The aim of this study was to report the diagnostic accuracy of clinical tests for anterior cruciate ligament tears (partial and complete) without concomitant knee ligament injury.Entities:
Keywords: ACL; ACL tear; Anterior drawer; Clinical diagnostic tests; Knee injuries; Lachman; Lever sign; Meta-analysis; Pivot shift; Sporting injuries
Mesh:
Year: 2022 PMID: 35150292 PMCID: PMC9464183 DOI: 10.1007/s00167-022-06898-4
Source DB: PubMed Journal: Knee Surg Sports Traumatol Arthrosc ISSN: 0942-2056 Impact factor: 4.114
Fig. 1PRISMA flow diagram showing selection process outcome. Retrieved studies were systematically excluded against the inclusion and exclusion criteria. Arrows pointing downwards indicate the process of identifying relevant articles. Arrows pointing to the right show articles excluded from the review
Study characteristics extracted from each full manuscript
| Study | Stated injury onset | Injury onset category | Study design | Blinding | Haemarthrosis | Random order of tests | Index test description | Gender | Age range | Duration Index test to reference standard |
|---|---|---|---|---|---|---|---|---|---|---|
| Blanke et al. 2020 [ | 6 weeks after injury | Non-acute | RCT | Examiner blinded to clinical history and group allocation | No data | Yes | Yes | 62 M 38 F | No data (ACL rupture -26.4 Controls—45.4) | No data |
| Bomberg et al. 1990 [ | “acute” | Acute | Prospective | No data | Present – no mention of action | No data | No | 31 M 14 F | 13–42 (21) | No data |
| Chong et al. 2017 [ | After 72 h | Unclear/ both | Retrospective | No data | No data | No | Yes | 21 M 12 F | 11–62 (30.9) | No data |
| Cooperman et al. 1990 [ | > 6 weeks from surgery | Non-acute | Prospective study on retrospectively diagnosed patients | Examiner blinded to patient’s face and torso. Patients wore the type of same shorts | No data | Yes | Yes | 18 M 14 F | 18–57 (26) | At least 6 weeks before the study |
| Dahlstedt et al. 1989 [ | < 22 days | Acute | Retrospective | No data | No data | No data | No | 20 M 21 F | 14–47 (27.5) | No data |
| Deveci et al. 2015[ | 4–25 weeks | Non-acute | Retrospective | No data | No data | No data | Lever test only | 96 M 21 F | 17–45 (25.8) | 4–25 weeks |
| Donaldson et al. 1985 [ | < 19 days | Acute | Retrospective | No data | No data | No data | Lachman only | 62 M 38 F | 15–49 (No data) | Within 19 days |
| Fok et al. 2014[ | > 1 month | Non-acute | Retrospective | No data | No data | No data | No data | 189 M 36 F | 16–52 (26.4) | 1–47 months |
| Geraets et al. 2015 [ | > 5 months | Non-acute | Prospective study on retrospectively diagnosed patients | Blinded to clinical data | No data | Yes | Yes | 41 M 19 F | 19–70 (37) | No data |
| Gurpinar et al. 2019 [ | < 2 weeks | Acute | Retrospective | Not blinded | Drained before examination | No | Yes | 69 M 9F | 17–44 (26.17) | No data |
| Jarbo et al. 2017 [ | < 4 weeks | Unclear/ both | Retrospective | Examiner blinded to clinical history, scans and randomly assigned tester | No data | No | Yes | 58 M 44 F | 15–66 (No data) | No data |
| Kostov et al. 2014 [ | Unclear | Unclear/ both | Retrospective | No data | No data | No data | Yes | 81 M 22 F | 16–58 (29.7) | No data |
| Krakowski et al. 2019 [ | mean 44 months | Non-acute | Retrospective | Not blinded | No data | No data | Yes | 47 M 49 F | No data (45) | 44 months average |
| Lee et al. 1988 [ | “most of our patients are nonacute” | Unclear/ both | Retrospective | No data | No data | No data | Yes | No data | 14–59 (No data) | Arthroscopy within 1–5 weeks after MRI |
| Lelli et al. 2016 [ | Acute – less than 20 days Chronic – 20 days to 4 years | Acute & Non-acute | Prospective | Blinded to MRI scan if available | No data | No data | Lever test only | 281 M 119 F | No data (26.4) | No data |
| Lichtenberg et al. 2018 [ | Acute, subacute and chronic (< 3; 3–11; > 12 weeks) | Unclear/ both | Prospective | Not blinded | No data | No | Yes | 57 M 37 F | No data (34) | No data |
| Liu et al. 1995 [ | Within 7 days | Acute | Retrospective | No data | No data | No data | Lachman only | 27 M 11 F | 16–35 (26) | Surgery within 3 weeks |
| Makki et al. 2019 [ | Unclear | Unclear/ both | Retrospective | No data | If present, joint aspiration performed | N/A – 1 test | No data | 44 M 26 F | 13–52 (28) | No data |
| McQuivey et al. 2019 [ | “acute” | Acute | Prospective | Not blinded to clinical history | No data | N/A – 1 test | Yes | 14 M 7 F | 12–54 (31.2) | No data |
| Mulligan et al. 2015 [ | > 30 weeks | Non-acute | Prospective | Examiner blinded to clinical history, MRI scan but not to the patient’s face | No data | Yes | Yes | 21 M 34 F | 20–64 (40.7) | No data |
| Peeler et al. 2010 [ | From 0 to 2143 days | Unclear/ both | Retrospective | No data | No data | No data | Yes | No data | 18–55 (No data) | “significant time elapsed” |
| Sandberg et al. 1986 [ | Average 7 days after injury | Acute | Retrospective | No data | Joint aspiration performed | No data | ADS & Lachman only | No data | 13–59 (27) | No data |
| Thapa et al. 2015 [ | Unclear | Unclear/ both | Prospective | No data | No data | No data | Lever test only | 50 M 30 F | 21–42 (32) | No data |
| Wagemakers et al. 2010 [ | 9–81 days | Unclear/ both | Prospective | Examiner blinded to MRI and clinical history | No data | No data | Yes | 74 M 60 F | No data (40.2) | Immediate– test after MRI |
The table reports data extracted from each study relevant to the study questions. RCT randomised controlled trial, M male, F female, N/A not applicable, ADS anterior drawer sign
Patient cohorts from studies
| Study | Injury onset | Complete or partial | Injury type | Reference standard | Test | Number of patients | TP | TN | FP | FN | SN | SP |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blanke et al. 2020 [ | Non-acute | Complete | Isolated ACL | A | Lachman | 100 (200) | 74 | 83 | 17 | 26 | 0.74 | 0.83 |
| Non-acute | Complete | Isolated ACL | A | Pivot | 100 (200) | 46 | 96 | 4 | 54 | 0.46 | 0.96 | |
| Bomberg et al. 1990 [ | Acute | Complete | Isolated ACL ± meniscal tear | A | ADS | 21 | 2 | 0 | 0 | 19 | 0.10 | – |
| Acute | Complete | Isolated ACL ± meniscal tear | A | Lachman | 21 | 18 | 0 | 0 | 3 | 0.86 | – | |
| Acute | Complete | Isolated ACL ± meniscal tear | A | Pivot | 21 | 9 | 0 | 0 | 12 | 0.43 | – | |
| Chong et al. 2017 [ | Unclear/ Both | C & P | Isolated ACL | A | Lachman (physician assistant) | 33 | 22 | 0 | 0 | 11 | 0.67 | – |
Unclear/ Both | C & P | Isolated ACL | A | Lachman (surgeon) | 33 | 31 | 0 | 0 | 2 | 0.94 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Lever (physician assistant) | 33 | 27 | 0 | 0 | 6 | 0.82 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Lever (surgeon) | 33 | 29 | 0 | 0 | 4 | 0.88 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Pivot (physician assistant) | 33 | 3 | 0 | 0 | 30 | 0.09 | – | |
Unclear/ Both | C & P | Isolated ACL | A | Pivot (surgeon) | 33 | 9 | 0 | 0 | 24 | 0.27 | – | |
| Cooperman et al. 1990 [ | Non-acute | Complete | Isolated ACL | A | Lachman (Trial 1) | 32 | 20 | 19 | 19 | 6 | 0.77 | 0.50 |
| Non-acute | Complete | Isolated ACL | A | Lachman (Trial 2) | 32 | 22 | 22 | 17 | 4 | 0.85 | 0.56 | |
| Dahlstedt et al. 1989 [ | Acute | Complete | Unclear | A | Lachman | 23 | 23 | 0 | 0 | 0 | 1.00 | – |
| Acute | Complete | Unclear | A | Pivot | 23 | 2 | 0 | 0 | 21 | 0.09 | – | |
| Deveci et al. 2015 [ | Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | ADS | 117 | 70 | 0 | 0 | 47 | 0.60 | – |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | Lachman | 117 | 94 | 0 | 0 | 23 | 0.80 | – | |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | Lever | 117 | 110 | 0 | 0 | 7 | 0.94 | – | |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | A | Pivot | 117 | 73 | 0 | 0 | 44 | 0.62 | – | |
| Donaldson et al. 1985 [ | Acute | Complete | Isolated ACL ± meniscal tear | A | ADS | 33 | 25 | 0 | 0 | 8 | 0.76 | – |
| Acute | Complete | Isolated ACL ± meniscal tear | A | Lachman | 33 | 33 | 0 | 0 | 0 | 1.00 | – | |
| Acute | Complete | Isolated ACL ± meniscal tear | A | Pivot | 33 | 14 | 0 | 0 | 19 | 0.42 | – | |
| Acute | Complete | Isolated ACL | A | ADS | 37 | 20 | 0 | 0 | 17 | 0.54 | – | |
| Acute | Complete | Isolated ACL | A | Lachman | 37 | 36 | 0 | 0 | 1 | 0.97 | – | |
| Acute | Complete | Isolated ACL | A | Pivot | 37 | 10 | 0 | 0 | 27 | 0.27 | – | |
| Fok et al. 2014 [ | Non-acute | Partial | Isolated ACL ± meniscal tear | A | Pivot | 6 | 5 | 0 | 0 | 1 | 0.83 | – |
| Non-acute | Partial | Isolated ACL ± meniscal tear | A | Lachman | 8 | 6 | 0 | 0 | 2 | 0.75 | – | |
| Non-acute | C & P | Isolated ACL ± meniscal tear | A | Pivot | 206 | 204 | 0 | 0 | 2 | 0.99 | – | |
| Non-acute | C & P | Isolated ACL ± meniscal tear | A | Lachman | 217 | 205 | 0 | 0 | 12 | 0.94 | – | |
| Geraets et al. 2015 [ | Non-acute | Complete | Isolated ACL | A | Lachman (primary care physician) | 60 | 12 | 26 | 12 | 10 | 0.55 | 0.68 |
| Non-acute | Complete | Isolated ACL | A | Lachman (surgeon) | 60 | 12 | 38 | 0 | 10 | 0.55 | 1.00 | |
| Gurpinar et al. 2019 [ | Acute | C & P | Isolated ACL ± meniscal tear | MRI | ADS | 78 | 48 | 11 | 5 | 14 | 0.77 | 0.69 |
| Acute | C & P | Isolated ACL ± meniscal tear | MRI | Lachman | 78 | 50 | 10 | 6 | 12 | 0.81 | 0.63 | |
| Acute | C & P | Isolated ACL ± meniscal tear | MRI | Lever | 78 | 57 | 15 | 1 | 5 | 0.92 | 0.94 | |
| Acute | C & P | Isolated ACL ± meniscal tear | MRI | Pivot | 78 | 32 | 15 | 1 | 30 | 0.52 | 0.94 | |
| Jarbo et al. 2017 [ | Unclear/ Both | Unclear | Unclear | MRI | Lever | 48 | 10 | 32 | 1 | 5 | 0.67 | 0.97 |
| Kostov et al. 2014 [ | Unclear/ Both | C & P | Unclear | A | ADS | 103 | 69 | 30 | 0 | 4 | 0.95 | 1.00 |
Unclear/ Both | C & P | Unclear | A | Lachman | 103 | 67 | 30 | 0 | 6 | 0.92 | 1.00 | |
Unclear/ Both | C & P | Unclear | A | Pivot | 103 | 45 | 29 | 1 | 28 | 0.62 | 0.97 | |
Unclear/ Both | C & P | Unclear | MRI | ADS | 103 | 59 | 28 | 10 | 6 | 0.91 | 0.74 | |
Unclear/ Both | C & P | Unclear | MRI | Lachman | 103 | 58 | 29 | 9 | 7 | 0.89 | 0.76 | |
Unclear/ Both | C & P | Unclear | MRI | Pivot | 103 | 42 | 34 | 4 | 23 | 0.65 | 0.89 | |
| Krakowski et al. 2019 [ | Non-acute | Complete | Isolated ACL ± meniscal tear | A | ADS | 96 | – | – | – | – | 0.69 | 0.93 |
| Non-acute | Complete | Isolated ACL ± meniscal tear | A | Lachman | 96 | 27 | 0 | 0 | 5 | 0.84 | 0.92 | |
| Non-acute | Complete | Isolated ACL ± meniscal tear | A | Lever | 96 | – | – | – | – | 0.63 | 0.98 | |
| Non-acute | Complete | Isolated ACL ± meniscal tear | A | Pivot | 96 | – | – | – | – | 0.43 | 0.98 | |
| Lee et al. 1988 [ | Unclear /Both | Unclear | Isolated ACL ± meniscal tear | A | ADS | 41 | 14 | 23 | 0 | 4 | 0.78 | 1.00 |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Lachman | 41 | 16 | 23 | 0 | 2 | 0.89 | 1.00 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | MRI | ADS | 79 | 18 | 56 | 0 | 5 | 0.78 | 1.00 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | MRI | Lachman | 79 | 21 | 56 | 0 | 2 | 0.91 | 1.00 | |
| Lelli et al. 2016 [ | Acute | Complete | Isolated ACL | MRI | ADS | 100 | 75 | 0 | 0 | 25 | 0.75 | – |
| Acute | Complete | Isolated ACL | MRI | Lachman | 100 | 66 | 0 | 0 | 34 | 0.66 | – | |
| Acute | Complete | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1.00 | – | |
| Acute | Complete | Isolated ACL | MRI | Pivot | 100 | 23 | 0 | 0 | 77 | 0.23 | – | |
| Non-acute | Complete | Isolated ACL | MRI | ADS | 100 | 100 | 0 | 0 | 0 | 1 | – | |
| Non-acute | Complete | Isolated ACL | MRI | Lachman | 100 | 100 | 0 | 0 | 0 | 1 | – | |
| Non-acute | Complete | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1 | – | |
| Non-acute | Complete | Isolated ACL | MRI | Pivot | 100 | 98 | 0 | 0 | 2 | 0.98 | – | |
| Acute | Partial | Isolated ACL | MRI | ADS | 100 | 29 | 0 | 0 | 71 | 0.29 | – | |
| Acute | Partial | Isolated ACL | MRI | Lachman | 100 | 42 | 0 | 0 | 58 | 0.42 | – | |
| Acute | Partial | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1.00 | – | |
| Acute | Partial | Isolated ACL | MRI | Pivot | 100 | 11 | 0 | 0 | 89 | 0.11 | – | |
| Non-acute | Partial | Isolated ACL | MRI | ADS | 100 | 83 | 0 | 0 | 17 | 0.83 | – | |
| Non-acute | Partial | Isolated ACL | MRI | Lachman | 100 | 39 | 0 | 0 | 61 | 0.39 | – | |
| Non-acute | Partial | Isolated ACL | MRI | Lever | 100 | 100 | 0 | 0 | 0 | 1 | – | |
| Non-acute | Partial | Isolated ACL | MRI | Pivot | 100 | 56 | 0 | 0 | 44 | 0.56 | – | |
| Lichtenberg et al. 2018 [ | Unclear/ Both | C & P | Unclear | A | Pivot | 81 | – | – | – | – | 0.50 | 0.98 |
Unclear/ Both | C & P | Unclear | A | Lever | 87 | – | – | – | – | 0.39 | 1 | |
Unclear/ Both | C & P | Unclear | A | ADS | 91 | – | – | – | – | 0.71 | 0.94 | |
Unclear/ Both | C & P | Unclear | A | Lachman | 93 | – | – | – | – | 0.87 | 0.91 | |
| Liu et al. 1995 [ | Acute | Complete | Unclear | A | ADS | 38 | 23 | 0 | 0 | 15 | 0.61 | – |
| Acute | Complete | Unclear | A | Lachman | 38 | 36 | 0 | 0 | 2 | 0.95 | – | |
| Acute | Complete | Unclear | A | Pivot | 38 | 27 | 0 | 0 | 11 | 0.71 | – | |
| Makki et al. 2019 [ | Unclear/ Both | C & P | Unclear | MRI | Lachman | 50 | 11 | 28 | 7 | 4 | 0.73 | 0.80 |
| McQuivey et al. 2019 [ | Acute | C & P | Isolated ACL | MRI | Lever | 21 | 3 | 17 | 1 | 0 | 1.00 | 0.94 |
| Mulligan et al. 2015 [ | Non-acute | Unclear | Unclear | A | Lachman | 17 | 14 | 1 | 0 | 2 | 0.88 | 1.00 |
| Peeler et al. 2010 [ | Unclear/ Both | Unclear | Unclear | A | ADS (physician) | unclear | – | – | – | – | 0.33 | – |
Unclear/ Both | Unclear | Unclear | A | ADS (surgeon) | unclear | – | – | – | – | 0.39 | – | |
Unclear/ Both | Unclear | Unclear | A | ADS (therapist) | unclear | – | – | – | – | 0.36 | – | |
Unclear/ Both | Unclear | Unclear | A | Lachman (physician) | unclear | – | – | – | – | 0.53 | – | |
Unclear/ Both | Unclear | Unclear | A | Lachman (surgeon) | unclear | – | – | – | – | 0.86 | – | |
Unclear/ Both | Unclear | Unclear | A | Lachman (therapist) | unclear | – | – | – | – | 0.27 | – | |
Unclear/ Both | Unclear | Unclear | A | Pivot (physician) | unclear | – | – | – | – | 0.15 | – | |
Unclear/ Both | Unclear | Unclear | A | Pivot (surgeon) | unclear | – | – | – | – | 0.63 | – | |
Unclear/ Both | Unclear | Unclear | A | Pivot (therapist) | unclear | – | – | – | – | 0.00 | – | |
| Sandberg et al. 1986 [ | Acute | Unclear | Isolated ACL ± meniscal tear | A | ADS | 92 | 37 | 0 | 0 | 55 | 0.40 | – |
| Acute | Unclear | Isolated ACL ± meniscal tear | A | Lachman | 92 | 40 | 0 | 0 | 52 | 0.43 | – | |
| Acute | Unclear | Isolated ACL ± meniscal tear | A | Pivot | 92 | 4 | 0 | 0 | 88 | 0.04 | – | |
| Thapa et al. 2015 [ | Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | ADS | 80 | 28 | 42 | 3 | 7 | 0.80 | 0.93 |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Lachman | 80 | 32 | 43 | 2 | 3 | 0.91 | 0.96 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Lever | 80 | 30 | 40 | 5 | 5 | 0.86 | 0.89 | |
Unclear/ Both | Unclear | Isolated ACL ± meniscal tear | A | Pivot | 80 | 18 | 45 | 0 | 17 | 0.51 | 1.00 | |
| Wagemakers et al. 2010 [ | Unclear/ Both | Complete | Isolated ACL ± meniscal tear | MRI | ADS | 64 | 15 | 26 | 21 | 2 | 0.88 | 0.55 |
Unclear/ Both | C & P | Isolated ACL ± meniscal tear | MRI | ADS | 64 | 23 | 20 | 16 | 5 | 0.82 | 0.56 |
Characterisation of patient cohorts within studies
C & P complete and partial, ADS anterior drawer sign, A arthroscopy, MRI Magnetic Resonance Imaging, ACL anterior cruciate ligament, SN sensitivity, SP specificity, TP true positives, TN true negatives, FP false positives, FN false negatives
QUADAS-2 tool assessment shows potential risks based on study’s design
Univariate and bivariate analysis of diagnostic clinical tests for all studies evaluated
| All studies [95% CI] | |||||
|---|---|---|---|---|---|
| Sn | Sp | LR+ | LR− | AUC | |
| Anterior Drawer (UA) | 0.75 [0.61; 0.86] | 0.92 [0.67; 0.99] | 2.4 [1.58; 3.64] | 0.28 [0.20; 0.42] | – |
| Anterior Drawer (BA) | 0.83 [0.77; 0.88] | 0.85 [0.64; 0.95] | 6.34 [2.32; 15.30] | 0.20 [0.14; 0.30] | 0.87 |
| Lachman (UA) | 0.85 [0.77; 0.91] | 0.93 [0.77; 0.98] | 2.72 [1.97; 3.77] | 0.27 [0.20; 0.36] | – |
| Lachman (BA) | 0.81 [0.73; 0.87] | 0.85 [0.73; 0.92] | 5.72 [2.82; 10.80] | 0.24 [0.15; 0.35] | 0.882 |
| Lever Sign (UA) | 0.98 [0.88; 1.00] | 0.93 [086; 0.96] | 4.56 [2.79; 7.45] | 0.15 [0.09; 0.26] | – |
| Lever Sign (BA) | 0.83 [0.68; 0.92] | 0.91 [0.83; 0.95] | 9.66 [5.01;17.30] | 0.18 [0.09; 0.34] | 0.938 |
| Pivot Shift (UA) | 0.48 [0.29; 0.68] | 0.96 [0.92; 0.98] | 1.45 [0.73; 2.87] | 0.52 [0.43; 0.64] | – |
| Pivot Shift (BA) | 0.55 [0.47; 0.62] | 0.94 [0.88; 0.97] | 10.70 [5.43; 19.30] | 0.48 [0.40; 0.56] | 0.828 |
AUC area under the curve, BA bivariate analysis, CI confidence interval, LR− negative likelihood ratio, LR+ positive likelihood ratio, Sn sensitivity, Sp specificity, UA univariate analysis
Comparison of diagnostic clinical tests (anterior drawer, Lachman, Lever sign and pivot shift) in complete and partial ACL tears, acute and post-acute clinical presentations with arthroscopy and MRI as the reference standard was performed using univariate and bivariate modelling
Fig. 2Fagan’s nomogram of shift in pre-test to post-test probability of clinical tests. Fagan’s nomograms illustrating the shift in pre-test to post-test probability for the a anterior drawer, b Lachman, c Lever sign and d Pivot shift tests. The pre-test probability of acute ACL tear is shown on the left vertical axis (36%). The post-test probability is shown on the right vertical axis. The middle vertical axis shows value of likelihood ratio. The blue line represents a change in ACL tear probability when the test is positive. The red line indicates a change in ACL injury probability when test is negative